Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,923 | 9,361 | 7,968 | 12,009 | 16,331 |
| Other current assets | 143 | 98 | 105 | 145 | 145 |
| TOTAL | $7,368 | $9,779 | $8,643 | $13,193 | $16,692 |
| Non-Current Assets | |||||
| PPE Net | 122 | 127 | 132 | 137 | 141 |
| Intangibles | 8,574 | 8,732 | 8,889 | 9,047 | 9,204 |
| Other Non-Current Assets | 0 | 0 | 0 | 32 | 79 |
| TOTAL | $8,696 | $8,859 | $9,021 | $9,215 | $9,425 |
| Total Assets | $16,065 | $18,637 | $17,663 | $22,408 | $26,117 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,120 | 660 | 1,395 | 2,434 | 2,552 |
| TOTAL | $1,120 | $660 | $1,395 | $2,467 | $2,634 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 162 | 164 | 93 | 58 | 84 |
| TOTAL | $162 | $164 | $93 | $58 | $84 |
| Total Liabilities | $1,282 | $824 | $1,488 | $2,525 | $2,718 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,705 | 1,266 | 1,044 | 1,043 | 1,042 |
| Retained earnings | -49,583 | -46,405 | -43,046 | -39,179 | -35,319 |
| Other shareholders' equity | -7 | -35 | -8 | -5 | -5 |
| TOTAL | $14,783 | $17,814 | $16,175 | $19,884 | $23,399 |
| Total Liabilities And Equity | $16,065 | $18,638 | $17,663 | $22,408 | $26,117 |